Lantheus' (LNTH) DEFINITY Approved by FDA for Pediatric Use
https://www.zacks.com/stock/news/2236099/lantheus-lnth-definity-approved-by-fda-for-pediatric-use?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2236099
Mar 05, 2024 - Lantheus' (LNTH) receipt of the expanded indication for DEFINITY is likely to address unmet medical needs of pediatric patients.
0
Boston Scientific (BSX) Grows IC Business With New FDA Nod
https://www.zacks.com/stock/news/2235447/boston-scientific-bsx-grows-ic-business-with-new-fda-nod?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2235447
Mar 04, 2024 - The AGENT DCB of Boston Scientific (BSX) is already available in Europe, parts of Asia Pacific and Latin America.
0
ICON (ICLR) Gains From Strategic Deals, New Innovations
https://www.zacks.com/stock/news/2235446/icon-iclr-gains-from-strategic-deals-new-innovations?cid=CS-ZC-FT-analyst_blog|zer_report_update-2235446
Mar 04, 2024 - ICON (ICLR) continues to evolve its collaboration and delivery models, invest in technology, and enhance its project and program management capabilities.
0
Reasons to Add ShockWave Medical (SWAV) to Your Portfolio Now
https://www.zacks.com/stock/news/2235442/reasons-to-add-shockwave-medical-swav-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2235442
Mar 04, 2024 - ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
0
Best Momentum Stocks to Buy for March 1st
https://www.zacks.com/commentary/2234303/best-momentum-stocks-to-buy-for-march-1st?cid=CS-ZC-FT-zacks_1_rank_additions|momentum_additions-2234303
Mar 01, 2024 - SPXC, CAH and TAST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 1, 2023.
0
Myriad Genetics (MYGN) to Evaluate MRD Testing With New Pact
https://www.zacks.com/stock/news/2234635/myriad-genetics-mygn-to-evaluate-mrd-testing-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2234635
Mar 01, 2024 - Myriad Genetics' (MYGN) MRD test is uniquely capable of detecting ctDNA at the lowest levels of detection, which is essential for a pan-cancer investigation.
0
Philips' (PHG) New Innovation to Boost Neurovascular Diagnosis
https://www.zacks.com/stock/news/2233236/philips-phg-new-innovation-to-boost-neurovascular-diagnosis?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2233236
Feb 28, 2024 - Philips (PHG) announces its latest Azurion neuro biplane system, which aims to improve the diagnosis of stroke and major neurovascular diseases. The system is designed for superior patient care.
0
Here's Why Investors Should Retain STERIS (STE) Stock for Now
https://www.zacks.com/stock/news/2232656/here-s-why-investors-should-retain-steris-ste-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2232656
Feb 27, 2024 - Investors are optimistic about STERIS (STE) on continuous recovery of healthcare procedures and upbeat 2024 guidance.
0
Quest Diagnostics' (DGX) New Pact to Reduce Food Insecurity
https://www.zacks.com/stock/news/2232652/quest-diagnostics-dgx-new-pact-to-reduce-food-insecurity?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2232652
Feb 27, 2024 - Quest Diagnostics' (DGX) recent collaboration aims to advance food access and healthy eating habits for underserved communities.
0
Here's Why You Should Buy Edward Lifesciences (EW) Stock Now
https://www.zacks.com/stock/news/2231893/here-s-why-you-should-buy-edward-lifesciences-ew-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2231893
Feb 26, 2024 - Investors are optimistic about Edward Lifesciences' (EW) progress with the Structural Heart business and strong TAVR potential.
0